首页>
外国专利>
METHOD OF CHRONIC CARDIAC DECOMPENSATION SEVERITY ASSESSMENT USING QUANTITATIVE CRITERIA FOR CHILDREN WITH INNATE HEART DISEASE
METHOD OF CHRONIC CARDIAC DECOMPENSATION SEVERITY ASSESSMENT USING QUANTITATIVE CRITERIA FOR CHILDREN WITH INNATE HEART DISEASE
展开▼
机译：基于定量标准的先天性心脏病儿童慢性心力衰竭严重程度评估方法
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine.;SUBSTANCE: invention refers to medicine, particularly to infant cardiology, and can be applied in assessment of chronic cardiac disease (CD) severity for children with innate heard diseases. It involves determination of level indicator for T-terminal predecessor of cerebral natriuretic peptide (NT-pro-BNP) as quantitative criterion. For NT-pro-BNP level value within 15 to 214 pg/ml, 1 functional class of cardiac decompensation is diagnosed (FC 1); for level value within 141 to 898 pg/ml FC 2 is diagnosed, for level value within 962 to 4993 pg/ml FC 3 is diagnosed, for level value within 3626 to 78616 pg/ml FC 4 is diagnosed.;EFFECT: objective and prompt assessment of cardiac decompensation level for the claimed group of patients, enabling timely surgical treatment.;2 tbl, 1 ex
展开▼
机译：技术领域本发明涉及医学，特别是涉及婴儿心脏病学，并且可以用于评估患有先天性听力疾病的儿童的慢性心脏病（CD）严重程度。它涉及确定脑钠肽前体T端水平指标（NT-pro-BNP）作为定量标准。对于NT-pro-BNP水平值在15到214 pg / ml之间的情况，诊断为心脏功能失代偿的1个功能类别（FC 1）;诊断为141至898 pg / ml FC 2内的水平值，诊断为962至4993 pg / ml FC 3内的水平值，诊断为3626至78616 pg / ml FC 4内的水平值。迅速评估所称患者组的心脏代偿失调水平，以便及时进行手术治疗。; 2 tbl，1 ex
展开▼
